These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36054609)

  • 1. Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry.
    Rosenbloom BE; Cappellini MD; Weinreb NJ; Dragosky M; Revel-Vilk S; Batista JL; Sekulic D; Mistry PK
    Am J Hematol; 2022 Oct; 97(10):1337-1347. PubMed ID: 36054609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of screening for gammopathies in children and adults with Gaucher disease type 1 in a cohort from Brazil and the United States.
    Abell K; Chadwell SE; Burrow TA; Becker APP; Bailey L; Steele P; Zhang X; Islas-Ohlmayer M; Bittencourt R; Schwartz IVD; Prada CE
    Am J Med Genet C Semin Med Genet; 2020 Dec; 184(4):1052-1059. PubMed ID: 33277783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
    El-Khoury H; Lee DJ; Alberge JB; Redd R; Cea-Curry CJ; Perry J; Barr H; Murphy C; Sakrikar D; Barnidge D; Bustoros M; Leblebjian H; Cowan A; Davis MI; Amstutz J; Boehner CJ; Lightbody ED; Sklavenitis-Pistofidis R; Perkins MC; Harding S; Mo CC; Kapoor P; Mikhael J; Borrello IM; Fonseca R; Weiss ST; Karlson E; Trippa L; Rebbeck TR; Getz G; Marinac CR; Ghobrial IM
    Lancet Haematol; 2022 May; 9(5):e340-e349. PubMed ID: 35344689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry.
    Nguyen Y; Stirnemann J; Lautredoux F; Cador B; Bengherbia M; Yousfi K; Hamroun D; Astudillo L; Billette de Villemeur T; Brassier A; Camou F; Dalbies F; Dobbelaere D; Gaches F; Leguy-Seguin V; Masseau A; Pers YM; Pichard S; Serratrice C; Berger MG; Fantin B; Belmatoug N; On Behalf Of The French Evaluation Of Gaucher Disease Treatment Committee
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32069933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher disease and cancer incidence: a study from the Gaucher Registry.
    Rosenbloom BE; Weinreb NJ; Zimran A; Kacena KA; Charrow J; Ward E
    Blood; 2005 Jun; 105(12):4569-72. PubMed ID: 15718419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Brazilian Rare-Disease Center's Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF.
    Vernet Machado Bressan Wilke M; Iop GD; Faqueti L; Lemos da Silva LA; Kubaski F; Poswar FO; Michelin-Tirelli K; Randon D; Borelli WV; Giugliani R; Schwartz IVD
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronous multiple myeloma and Gaucher disease.
    Monge J; Chadburn A; Gergis U
    Hematol Oncol Stem Cell Ther; 2020 Mar; 13(1):42-45. PubMed ID: 31622574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased incidence of cancer in adult Gaucher disease in Western Europe.
    de Fost M; Vom Dahl S; Weverling GJ; Brill N; Brett S; Häussinger D; Hollak CE
    Blood Cells Mol Dis; 2006; 36(1):53-8. PubMed ID: 16246599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance.
    Giuffrida G; Markovic U; Condorelli A; Duminuco A; Calafiore V; Conticello C; Romano A; Grasso S; Riccobene C; Ragusa MTV; Esposito B; Nicolosi D; Calagna M; Nardo A; Consoli U; Uccello G; Di Giacomo V; Neri S; Cingari MR; Rodà F; Innao V; Fiumara A; Duro G; Zizzo C; Di Raimondo F
    Eur J Haematol; 2023 Dec; 111(6):922-929. PubMed ID: 37747757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease.
    Hughes D; Cappellini MD; Berger M; Van Droogenbroeck J; de Fost M; Janic D; Marinakis T; Rosenbaum H; Villarubia J; Zhukovskaya E; Hollak C
    Br J Haematol; 2007 Sep; 138(6):676-86. PubMed ID: 17655728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Czech Registry of Monoclonal Gammopathies - Technical Solution, Data Collection and Visualisation.
    Brozova L; Schwarz D; Snabl I; Kalina J; Pavlickova B; Komenda M; Jarkovský J; Němec P; Horinek D; Stefanikova Z; Pour L; Hájek R; Maisnar V
    Klin Onkol; 2017; 30(Supplementum2):43-50. PubMed ID: 28903570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry.
    Rosenbloom B; Balwani M; Bronstein JM; Kolodny E; Sathe S; Gwosdow AR; Taylor JS; Cole JA; Zimran A; Weinreb NJ
    Blood Cells Mol Dis; 2011 Jan; 46(1):95-102. PubMed ID: 21067946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature.
    Arends M; van Dussen L; Biegstraaten M; Hollak CE
    Br J Haematol; 2013 Jun; 161(6):832-42. PubMed ID: 23594419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymptomatic and Treatment-requiring Multiple Myeloma - Data from the Czech Registry of Monoclonal Gammopathies.
    Brozova L; Jarkovský J; Pour L; Minárik J; Jungová A; Gregora E; Spicka I; Maisnar V; Hájek R
    Klin Onkol; 2017; 30(Supplementum2):51-59. PubMed ID: 28903571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Monoclonal Gammopathy of Undetermined Significance (MGUS): The experience from the specialized registry of hematologic malignancies of Basse-Normandie (France).
    Cabrera Q; Macro M; Hebert B; Cornet E; Collignon A; Troussard X
    Cancer Epidemiol; 2014 Aug; 38(4):354-6. PubMed ID: 24880205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
    Khan A; Hangartner T; Weinreb NJ; Taylor JS; Mistry PK
    J Bone Miner Res; 2012 Aug; 27(8):1839-48. PubMed ID: 22692814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Gammopathy of Undetermined Significance.
    Gonsalves WI; Rajkumar SV
    Ann Intern Med; 2022 Dec; 175(12):ITC177-ITC192. PubMed ID: 36508741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conduct in case of monoclonal gammapathy ?].
    Decaux O
    Rev Prat; 2018 Sep; 68(7):777-784. PubMed ID: 30869332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic.
    Zimran A; Liphshitz I; Barchana M; Abrahamov A; Elstein D
    Blood Cells Mol Dis; 2005; 34(3):197-200. PubMed ID: 15885601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MGUS, lymphoplasmacytic malignancies, and Gaucher disease: the significance of the clinical association.
    Weinreb NJ; Mistry PK; Rosenbloom BE; Dhodapkar MV
    Blood; 2018 May; 131(22):2500-2501. PubMed ID: 29650800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.